Sandeep Patel, DO
Gastroenterology · San Antonio, TXNPI 1497764740
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Conmed Corporation at 35.3% of the total. Reporting peaked in 2022 at $64,981 and has fallen 50.7% since, to $32,034 in 2025. Among gastroenterology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 478 payments — averaging $610.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conmed Corporation$103K
- Boston Scientific$93K
- AbbVie$45K
- Olympus Corporation$14K
- Olympus America Inc.$13K
- Shionogi Inc$8K
- plus $15K from 18 others
Across 15 payments — averaging $8376.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$126K
What the payments were for
- Consulting fees$147,42250%
- Speaking & faculty fees$89,34531%
- Travel & lodging$25,9909%
- Food & beverage$19,9767%
- Education$9,2003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conmed Corporation | 70 | $102,922 |
| Boston Scientific | 170 | $93,055 |
| AbbVie | 54 | $45,336 |
| Olympus Corporation | 5 | $14,300 |
| Olympus America Inc. | 81 | $13,417 |
| Shionogi Inc | 12 | $7,672 |
| Pentax Of America, Inc. | 12 | $5,607 |
| Ambu Inc. | 9 | $4,221 |
| Olympus Corporation Of The Americas | 24 | $3,642 |
| Ipsen Biopharmaceuticals, Inc | 13 | $356 |
| Apollo Endosurgery US Inc | 3 | $216 |
| Lumendi LLC | 2 | $208 |
| ERBE USA Inc | 5 | $187 |
| Bone Support Inc. | 1 | $148 |
| Fujifilm Healthcare Americas Corporation | 1 | $120 |
| Johnson & Johnson | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 1 | $105 |
| Micro-tech Endoscopy USA, Inc. | 2 | $79 |
| 3-d Matrix, Inc. | 1 | $75 |
| Iterative Scopes, Inc. | 1 | $42 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$31,991
- CONMED BILIARY$23,083
- GENERAL - THERAPIES$19,331
- GORE VIABIL$17,011
- CONMED GASTROSTOMY$14,750
- SPYGLASS$13,357
- BEAMER SYSTEM$11,996
- VISIGLIDE$11,553
- VISICLEAR$11,500
- STONE BALLOONS$10,400
- GUIDEWIRES$10,400
- PAPILLOTOME$10,400
- DISPOSABLE TRIPLE LUMEN SPHINCTEROTOME$9,634
- HANAROSTENT Esophagus TTS(CCC)$9,587
- CONMED HEMOSTASIS$8,979
- Mulpleta$7,360
- Resolution 360 Clip$5,987
- HEMOSTASIS CLIP$4,025
- Single Use Electrosurgical Knife KD-655$2,194
- EXALT Model D$2,001
How this compares
$291,933 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 94 | $269,225 |
| ZenpepLipase/Protease/Amylase | 22 | $87,591 |
| PertzyeLipase/Protease/Amylase | 19 | $70,456 |
| Dexlansoprazole DrDexlansoprazole | 21 | $6,104 |
| Ursodiol | 16 | $2,351 |
| Pantoprazole Sodium | 31 | $674 |
| Metoclopramide Hcl | 21 | $357 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $45,336 | $269,22594 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in San Antonio
- Eric LawitzSan Antonio$776K
- Charles RandallSan Antonio$749K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.